Beta Drugs Limited (NSE:BETA)
India · Delayed Price · Currency is INR 1,423.40
-6.10 (-0.43%)
At close: Jun 1, 2026
Beta Drugs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 414.83 | 424.19 | 364.37 | 307.19 | 248.28 |
Depreciation & Amortization | 171.53 | 113.75 | 97.82 | 104.1 | 72.54 |
Other Amortization | - | 11.39 | - | - | - |
Other Operating Activities | 56.38 | 2.39 | -17.12 | 19.47 | 73.18 |
Change in Accounts Receivable | -165.53 | -233.38 | -165.17 | -175.41 | -113.05 |
Change in Inventory | -146.91 | -99.6 | -191.94 | -81.37 | -64.39 |
Change in Accounts Payable | 93.51 | 119.76 | 190.33 | 82.88 | 114.58 |
Change in Other Net Operating Assets | -50.94 | 22.96 | 31.01 | -23.04 | -34.86 |
Operating Cash Flow | 372.86 | 361.44 | 309.3 | 233.83 | 296.28 |
Operating Cash Flow Growth | 3.16% | 16.86% | 32.28% | -21.08% | 59.29% |
Capital Expenditures | -534.82 | -368.59 | -116.16 | -182.12 | -194.28 |
Investment in Securities | - | - | 7.79 | - | - |
Other Investing Activities | 98.6 | 51.1 | 10.84 | 6.63 | 4.52 |
Investing Cash Flow | -513.91 | -357.18 | -139.72 | -190.69 | -217.55 |
Short-Term Debt Issued | - | 7.56 | - | 43.14 | 12.14 |
Long-Term Debt Issued | 63.3 | 1,237 | - | - | 6.08 |
Total Debt Issued | 63.3 | 1,245 | - | 43.14 | 18.22 |
Short-Term Debt Repaid | -60.12 | - | -41.11 | - | - |
Long-Term Debt Repaid | -0.79 | - | -5.59 | -43.73 | - |
Total Debt Repaid | -60.91 | - | -46.7 | -43.73 | - |
Net Debt Issued (Repaid) | 2.4 | 1,245 | -46.7 | -0.59 | 18.22 |
Issuance of Common Stock | 0.42 | 4.81 | - | - | - |
Other Financing Activities | -83.53 | -69.89 | -28.2 | -24.15 | -27.95 |
Financing Cash Flow | -80.71 | 1,180 | -74.9 | -24.74 | -9.74 |
Miscellaneous Cash Flow Adjustments | - | - | - | -0 | - |
Net Cash Flow | -221.76 | 1,184 | 94.69 | 18.4 | 68.99 |
Free Cash Flow | -161.95 | -7.14 | 193.15 | 51.71 | 102 |
Free Cash Flow Growth | - | - | 273.55% | -49.31% | -20.59% |
Free Cash Flow Margin | -4.21% | -0.20% | 6.53% | 2.28% | 5.55% |
Free Cash Flow Per Share | -15.98 | -0.71 | 20.09 | 5.12 | 10.11 |
Cash Interest Paid | 153.11 | 46.08 | 9.81 | 22.8 | 17.89 |
Levered Free Cash Flow | -335.9 | -88.99 | 134.52 | -17.57 | 0.72 |
Unlevered Free Cash Flow | -240.2 | -46.86 | 151.25 | -3.32 | 11.9 |
Change in Working Capital | -269.87 | -190.28 | -135.77 | -196.94 | -97.72 |